Several tumor markers, such as carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC) and cytokeratin 19-fragment (CYFRA 21-1), are used in clinical diagnosis as well as in patient’s follow-up. This evidence concerns the gene SERPINB3 and neoplasm.